| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/13/2011 | WO2011004017A1 1-(6 members azo-heterocyclic)-pyrrolin-2-one compounds as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic use |
| 01/13/2011 | WO2011003876A1 New antiviral compounds useful for the treatment or the prevention of epidemic keratoconjonctivitis |
| 01/13/2011 | WO2011003626A1 INDUCTION OF α-HELIX CONFORMATIONS IN PROTEINS AND PEPTIDES |
| 01/13/2011 | WO2011003236A1 The preparation and uses of a longan seed extract |
| 01/13/2011 | WO2011003138A1 Immunomodulating compositions comprising interleukin 13 inhibitors and uses therefor |
| 01/13/2011 | WO2010130708A9 Beta-lactamase inhibitors |
| 01/13/2011 | WO2010128346A3 Rosuvastatin manganse, copper, iron and zinc salts with high photochemical stability |
| 01/13/2011 | WO2010123200A3 Bacteriophage which kills pathogenic enteric bacteria |
| 01/13/2011 | WO2010111171A3 Enhanced treatments to kill or debilitate pathogenic microorganisms of a mammalian body |
| 01/13/2011 | WO2010105191A3 Antimicrobial compositions and methods of use therefore |
| 01/13/2011 | WO2010104341A3 Compositions for diagnosis of fungal infections |
| 01/13/2011 | WO2010102120A9 Methods and compositions to diagnose pain |
| 01/13/2011 | WO2010101649A3 Sigma 1 receptor inhibition as a novel therapeutical approach against hepatitis c virus infection |
| 01/13/2011 | WO2010099169A3 A novel in vitro hiv-1 latency model for screening reactivation agents of hiv-1 |
| 01/13/2011 | WO2010098843A3 Peptoid oligomers, pharmaceutical compositions and methods of using the same |
| 01/13/2011 | WO2010056633A8 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 01/13/2011 | WO2010046780A3 Anti viral compounds |
| 01/13/2011 | WO2010043650A3 Amino acid sequences targeting human cd4, cxcr4, ccr5, tlr4, alphav integrin, beta3- integrin, betal -integrin, human alpha2- integrin, cd81, sr-bi, claudin-i, claudin-6 and claudin-9, respectively, and neutralizing viral entry |
| 01/13/2011 | WO2010014943A3 Methionine analogs and methods of using same |
| 01/13/2011 | US20110009831 Antimicrobial coating for dermally invasive devices |
| 01/13/2011 | US20110009625 Novel compounds |
| 01/13/2011 | US20110009602 Human cd28 specific monoclonal antibodies for antigen-nonspecific activation of t-lymphocytes |
| 01/13/2011 | US20110009481 Medicament for the treatment of viral skin and tumour diseases |
| 01/13/2011 | US20110009478 Theranostic polycation beacons comprising oligoethyleneamine repeating units and lanthanide chelates |
| 01/13/2011 | US20110009476 Transcription factor decoys, compositions and methods |
| 01/13/2011 | US20110009471 Oligonucleotide analogues and methods utilizing the same |
| 01/13/2011 | US20110009463 Geranylgeranyl transferase inhibitors and methods of making and using the same |
| 01/13/2011 | US20110009456 Compounds, Compositions and Methods for Treatment and Prevention of Orthopoxvirus Infections and Associated Diseases |
| 01/13/2011 | US20110009452 Hydroxyalkanyl amides as modulators of chemokine receptor activity |
| 01/13/2011 | US20110009424 Co-Crystals and Pharmaceutical Compositions Comprising the same |
| 01/13/2011 | US20110009411 Therapeutic compositions and the use thereof |
| 01/13/2011 | US20110009408 Methods for identifiying inhibitors against viruses that use a class i fusion protein |
| 01/13/2011 | US20110009396 Tricyclic compounds for the treatment of inflammatory disorders |
| 01/13/2011 | US20110009394 Tricyclic nitrogen compounds and their use as antibacterial agents |
| 01/13/2011 | US20110009391 Tetrahydroquinoxaline urea derivatives, their preparation and their therapeutic application |
| 01/13/2011 | US20110009390 2-oxo-2- (2-phenyl-5,6,7,8-tetrahydro-indolizin-3-yl) -acetamide derivatives and related compounds as antifungal agents |
| 01/13/2011 | US20110009382 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles |
| 01/13/2011 | US20110009377 Azetidine derivatives, their preparation and their application in therapy |
| 01/13/2011 | US20110009371 Synthesis of tetracyclines and analogues thereof |
| 01/13/2011 | US20110009369 Anti-influenza compounds |
| 01/13/2011 | US20110009368 Solid forms of tenofovir disoproxil |
| 01/13/2011 | US20110009366 Bicyclic pyrimidinones and uses thereof |
| 01/13/2011 | US20110009365 Derivatives of indole-2-carboxamides and of azaindole-2-carboxamides substituted with a silanyl group, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009356 Novel phosphorus-containing prodrugs |
| 01/13/2011 | US20110009355 Azapeptide Derivatives |
| 01/13/2011 | US20110009313 Polyethylene glycolated lactoferrin complex and method of producing the same |
| 01/13/2011 | US20110008474 Topical Antifungal Composition |
| 01/13/2011 | US20110008472 Anti-methicillin-resistant staphylococcus aureus agent and anti-vancomycin-resistant enterococcus agent |
| 01/13/2011 | US20110008434 Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
| 01/13/2011 | US20110008430 Solid Pharmaceutical Dosage Form |
| 01/13/2011 | US20110008429 Anti-Retroviral Combination |
| 01/13/2011 | US20110008420 Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide |
| 01/13/2011 | US20110008419 Vaccine Against Streptococcus Pneumoniae |
| 01/13/2011 | US20110008417 Immunomodulating compositions and uses therefor |
| 01/13/2011 | US20110008414 Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines |
| 01/13/2011 | US20110008402 Souluble b-n-acetylglucoseaminidase based antibiofilm compositions and uses thereof |
| 01/13/2011 | US20110008389 Recombinant attenuated clostridium organisms and vaccine |
| 01/13/2011 | US20110008387 Composition containing hcmv particles |
| 01/13/2011 | US20110008385 Immunogenic composition |
| 01/13/2011 | US20110008384 Antiviral activity from medicinal mushrooms |
| 01/13/2011 | US20110008380 Anaplasma Phagocytophilum (Aph) Antigens and Antibodies Specific for Anaplasma |
| 01/13/2011 | US20110008378 Modified flagellin improved toll-like receptor 5 stimulating activity |
| 01/13/2011 | US20110008361 Treatment Method |
| 01/13/2011 | US20110008360 Human antibodies against rabies and uses thereof |
| 01/13/2011 | US20110008357 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 01/13/2011 | US20110008353 Identification of astrovirus va1 associated with gastroenteritis in humans |
| 01/13/2011 | US20110008352 Toll-Like Receptor 3 Antagonists |
| 01/13/2011 | US20110008351 Anticomplement polypeptides of ixodes ricinus |
| 01/13/2011 | US20110008348 Soluble fragments of influenza virus pb2 protein capable of binding rna-cap |
| 01/13/2011 | US20110008338 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008337 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008336 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008335 Methods and Compositions for Increasing the Efficiency of Therapeutic Antibodies Using NK Cell Potentiating Compounds |
| 01/13/2011 | US20110008332 Combination Therapy to Treat Persistent Viral Infections |
| 01/13/2011 | US20110008331 Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response |
| 01/13/2011 | US20110008329 Methods of Treating RSV Infections And Related Conditions |
| 01/13/2011 | US20110008326 Binding agents directed against il-4 receptor for the treatment of tumors, inflammatory and immunological disorders |
| 01/13/2011 | US20110008303 Methods for treatment and prevention of mrsa/mssa |
| 01/13/2011 | US20110008291 Use of antifungal compositions to treat upper gastrointestinal conditions |
| 01/13/2011 | US20110008288 Hepatitis c virus inhibitors |
| 01/13/2011 | US20110008286 Novel proline substituted cyclosporin analogues |
| 01/13/2011 | US20110008285 Novel cyclosporin analogues |
| 01/13/2011 | US20110008284 Novel clyclosporin analogues |
| 01/13/2011 | US20110008280 Methods for treating viral infection using il-28 and il-29 cysteine mutants |
| 01/13/2011 | US20110008268 Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity |
| 01/13/2011 | US20110008267 Pharmaceutical and Cosmeceutical Wash-Off Mousse Shampoo Compositions, Processes for Preparing the Same and Uses Thereof |
| 01/13/2011 | US20110008266 Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| 01/13/2011 | US20110008256 Monoclonal antibodies that bind or neutralize dengue virus |
| 01/13/2011 | US20110008251 Methods for Generating Stably Linked Complexes Composed of Homodimers, Homotetramers or Dimers of Dimers and Uses |
| 01/13/2011 | US20110008250 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110005518 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics |
| 01/13/2011 | US20110005079 Washable Personal Grooming Device, in Particular Hair Removal Device, and Method for the Production of Components of Such a Device |
| 01/13/2011 | DE102009032902A1 Induktion von α-Helix-Konformationen in Proteinen und Peptiden Induction of α-helical conformations in proteins and peptides |
| 01/13/2011 | CA2803282A1 Methods for preparing vesicles and formulations produced therefrom |
| 01/13/2011 | CA2769488A1 Topical antifungal composition |
| 01/13/2011 | CA2767785A1 Diyne compositions |
| 01/13/2011 | CA2767474A1 Substituted pyrrolidinone as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic use |
| 01/13/2011 | CA2767467A1 1-(6 members azo-heterocyclic)-pyrrolin-2-one compounds as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic use |
| 01/13/2011 | CA2767392A1 Methods for preparing vesicles and formulations produced therefrom |
| 01/13/2011 | CA2767168A1 Sodium thiosulfate-containing pharmaceutical compositions |